|
An over-the-counter medication that is
also used as a green food coloring may help lower the risk
of liver cancer caused by aflatoxins, US and Chinese researchers
report.
Aflatoxins are carcinogens produced by
fungus that are found in soybeans, peanuts, corn and grains.
The new study found that chlorophyllin
given to healthy adults
reduced their levels of a marker of aflatoxin-DNA damage.
High levels of this marker are associated with increased liver
cancer risk.
Chlorophyllin is marketed as a drug (Derifil)
to control body and fecal odor in geriatric patients. Previous
studies have shown that chlorophyllin blocked the action of
cancer-causing agents in the liver of rodents.
To test whether the compound had the
same effect in humans, the researchers assigned 180 healthy
adults in China to consume 100 milligrams (mg) of chlorophyllin
or an inactive placebo pill three times a day for 4 months.
Levels of the aflatoxin-DNA damage marker were measured in
urine samples taken 3 months into the study.
According to results, adults who had
consumed chlorophyllin experienced
a 55% reduction in levels of this marker
compared with adults who had taken the placebo.
The findings suggest that taking chlorophyllin
as a preventive measure may help lower the risk of liver cancer.
Prophylactic interventions with chlorophyllin
or supplementation of diets with foods rich in chlorophylls
may represent practical means to prevent the development of
liver cancer or other environmentally induced cancers.
Previous research indicates that natural
chlorophylls in green plants may also lower the risk of cancer
in animals. These
compounds have been shown to alter the toxic effects of certain
cancer-causing compounds on genes.
"Thus, supplementation of diets
with foods rich in chlorophylls may be an effective approach
to chemoprevention and yet even simpler to implement in many
regions of the world," they conclude.
In the US, the rate liver cancer is increasing.
About 16,200 new cases will be diagnosed in the United States
during 2001, and an estimated 14,100 people will die of the
disease, according to the American Cancer Society.
Proceedings
of the National Academy of Sciences 2001;98:14601-14606
|